The three CCP-related gene signatures–HSD11B1, NDRG1 and CDCA3–may each independently predict the clinical outcomes of cutaneous melanoma patients, according to our prognostic study (both in OS and DSS). This evidence concerns the gene HSD11B1 and cutaneous melanoma.